Prevalence of thyroid cancer in hyperthyroidism treated by surgery

Kaohsiung Journal of Medical Sciences

Volumn 19, Issue 8, 2003, Pages 379-383

  Lin, Chih Hsin ^a   Chiang, Feng Yu ^a   Wang, Ling Feng ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Graves' disease; Hyperthyroidism; Thyroid cancer

Indexed keywords

DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; COMORBIDITY; DIAGNOSTIC ACCURACY; FEMALE; FOLLICULAR CARCINOMA; GOITER; GRAVES DISEASE; HISTOPATHOLOGY; HUMAN; HYPERTHYROIDISM; LOBECTOMY; MALE; PAPILLARY CARCINOMA; PREVALENCE; RETROSPECTIVE STUDY; SIDE EFFECT; THYROID CANCER; THYROIDECTOMY; TOXIC GOITER; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 0141792186     PISSN: 02575655     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1607-551x(09)70480-2     Document Type: Article

References (19)

1. Shapiro SJ, Friedman NB, Perzik SL, Catz B. Incidence of thyroid carcinoma in Graves' disease. Cancer 1970;26:1261-70.
2. Pomorski L, Cywinski J, Rybinski K. Cancer in hyperthyroidism. Neoplasma 1996;43:217-9.
3. Zanella E, Rulli F, Sianesi M, et al. Hyperthyroidism with concurrent thyroid cancer. Ann Ital Chir 2001;72:293-7.
4. Vaiana R, Cappelli C, Perini P, et al. Hyperthyroidism and concurrent thyroid cancer. Tumori 1999;85:247-52.
5. Ruggieri M, Scocchera F, Genderini M, et al. Hyperthyroidism and concurrent thyroid carcinoma. Eur Rev Med Pharmacol Sci 1999;3:265-8.
6. Hedinger C, Sobin LH. Histological typing of thyroid tumors. In: International Histological Classification of Tumors, volume 11. Geneva: World Health Organization, 1974:17-27.
7. Means IH. The Thyroid and its Diseases. Philadelphia: Lippincott, 1937:482.
8. Cantalamessa L, Baldini M, Orsatti A, et al. Thyroid nodules in Graves' disease and the risk of thyroid carcinoma. Arch Intern Med 1999;159:1705-8.
9. Behar R, Arganini M, Wu TC, et al. Graves' disease and thyroid cancer. Surgery 1986;100:1121-6.
10. Belfiore A, Garofalo MR, Giuffrida D, et al. Increased aggressiveness of thyroid cancer in patients with Graves' disease. J Clin Endocrinol Metab 1990;70:830-5.
11. Filetti S, Belfiore A, Amir SM, et al. The role of thyroid-stimulating antibodies of Graves' disease in differentiated thyroid cancer. N Engl J Med 1988;318:753-9.
12. Valenti TM, Macchia E, Pisa R, et al. Toxic adenoma and papillary thyroid carcinoma in a patient with Graves' disease. J Endocrinol Invest 1999;22:701-4.
13. Delange F, Lecomte P. Iodine supplementation: benefits outweigh risks. Drug Saf 2000;22:89-95.
14. Williams ED, Doniach I, Bjarnason O, Michie W. Thyroid cancer in an iodide rich area: a histopathological study. Cancer 1977;39:215-22.
15. Ozaki O, Ito K, Kobayashi K, et al. Thyroid carcinoma in Graves' disease. World J Surg 1990;14:437-40.
16. Vini L, Hyer S, Pratt B, Harmer C. Good prognosis in thyroid cancer found incidentally at surgery for thyrotoxicosis. Postgrad Med J 1999;75:169-70.
17. Chao TC, Lin JD, Jeng LB, Chen MF. Thyroid cancer with concurrent hyperthyroidism. Arch Surg 1999;134:130-4.
18. Higashi T, Itoh K, Ozaki O, et al. Diagnosis of thyroid carcinoma in Graves' disease by thyroid calcification. Rinsho Hoshasen 1988;33:351-6. (In Japanese)
19. Werga-Kjellman P, Zedenius J, Tallstedt L, et al. Surgical treatment of hyperthyroidism: a ten-year experience. Thyroid 2001;11:187-92.